These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 7529455)

  • 1. Fetal globin stimulation during a short-term trial of erythropoietin in HbS/beta-thalassemia patients.
    Bourantas KL; Georgiou I; Seferiadis K
    Acta Haematol; 1994; 92(2):79-82. PubMed ID: 7529455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Augmentation by erythropoietin of the fetal-hemoglobin response to hydroxyurea in sickle cell disease.
    Rodgers GP; Dover GJ; Uyesaka N; Noguchi CT; Schechter AN; Nienhuis AW
    N Engl J Med; 1993 Jan; 328(2):73-80. PubMed ID: 7677965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A short-term trial of butyrate to stimulate fetal-globin-gene expression in the beta-globin disorders.
    Perrine SP; Ginder GD; Faller DV; Dover GH; Ikuta T; Witkowska HE; Cai SP; Vichinsky EP; Olivieri NF
    N Engl J Med; 1993 Jan; 328(2):81-6. PubMed ID: 7677966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of the clinical severity of sickle cell/beta-thalassemia with hydroxyurea: the experience of a single center in Greece.
    Loukopoulos D; Voskaridou E; Kalotychou V; Schina M; Loutradi A; Theodoropoulos I
    Blood Cells Mol Dis; 2000 Oct; 26(5):453-66. PubMed ID: 11112383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of beta-thalassemia patients with recombinant human erythropoietin: effect on transfusion requirements and soluble adhesion molecules.
    Chaidos A; Makis A; Hatzimichael E; Tsiara S; Gouva M; Tzouvara E; Bourantas KL
    Acta Haematol; 2004; 111(4):189-95. PubMed ID: 15153710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the use of hydroxyurea/erythropoietin combination therapy for sickle cell disease.
    el-Hazmi MA; al-Momen A; Kandaswamy S; Huraib S; Harakati M; al-Mohareb F; Warsy AS
    Acta Haematol; 1995; 94(3):128-34. PubMed ID: 7502628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CNTO 530 increases expression of HbA and HbF in murine models of β-thalassemia and sickle cell anemia.
    Makropoulos DA; Achuthanandam R; Avery J; Wilson K; Brosnan K; Miller A; Nesspor T; Chroscinski D; Walker M; Egenolf D; Huang C; Bugelski PJ
    Curr Pharm Biotechnol; 2013; 14(2):242-8. PubMed ID: 23157711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of fetal hemoglobin synthesis with recombinant human erythropoietin in anemic patients with heterozygous beta-thalassemia during pregnancy.
    Breymann C; Fibach E; Visca E; Huettner C; Huch A; Huch R
    J Matern Fetal Med; 1999; 8(1):1-7. PubMed ID: 10052837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concordant fetal hemoglobin response to hydroxyurea in siblings with sickle cell disease.
    Steinberg MH; Voskaridou E; Kutlar A; Loukopoulos D; Koshy M; Ballas SK; Castro O; Barton F
    Am J Hematol; 2003 Feb; 72(2):121-6. PubMed ID: 12555216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased erythropoietin level induced by hydroxyurea treatment of sickle cell patients.
    Papassotiriou I; Voskaridou E; Stamoulakatou A; Loukopoulos D
    Hematol J; 2000; 1(5):295-300. PubMed ID: 11920206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic manipulation of fetal hemoglobin levels in sickle cell diseases and thalassemia: promise and reality.
    Pearson HA
    Adv Pediatr; 1996; 43():309-34. PubMed ID: 8794181
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacological induction of fetal hemoglobin in sickle cell disease and beta-thalassemia.
    Atweh GF; Loukopoulos D
    Semin Hematol; 2001 Oct; 38(4):367-73. PubMed ID: 11605172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Administration of high doses of recombinant human erythropoietin to patients with beta-thalassemia intermedia: a preliminary trial.
    Bourantas K; Economou G; Georgiou J
    Eur J Haematol; 1997 Jan; 58(1):22-5. PubMed ID: 9020369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral isobutyramide reduces transfusion requirements in some patients with homozygous beta-thalassemia.
    Reich S; Bührer C; Henze G; Ohlendorf D; Mesche M; Sinha P; Kage A; Müller C; Vetter B; Kulozik AE
    Blood; 2000 Nov; 96(10):3357-63. PubMed ID: 11071627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of fetal globin in beta-thalassemia: Cellular obstacles and molecular progress.
    Perrine SP; Castaneda SA; Boosalis MS; White GL; Jones BM; Bohacek R
    Ann N Y Acad Sci; 2005; 1054():257-65. PubMed ID: 16339673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of HBG mRNA in primary erythroid cultures: prediction of the response to hydroxyurea in sickle cell and beta-thalassemia.
    Pecoraro A; Rigano P; Troia A; Calzolari R; Scazzone C; Maggio A; Steinberg MH; Di Marzo R
    Eur J Haematol; 2014 Jan; 92(1):66-72. PubMed ID: 24112139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydroxyurea therapy in thalassemia.
    Loukopoulos D; Voskaridou E; Stamoulakatou A; Papassotiriou Y; Kalotychou V; Loutradi A; Cozma G; Tsiarta H; Pavlides N
    Ann N Y Acad Sci; 1998 Jun; 850():120-8. PubMed ID: 9668534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral sodium phenylbutyrate therapy in homozygous beta thalassemia: a clinical trial.
    Collins AF; Pearson HA; Giardina P; McDonagh KT; Brusilow SW; Dover GJ
    Blood; 1995 Jan; 85(1):43-9. PubMed ID: 7528572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical observation on YiSuiShengXueGranule on treating 156 patients with beta-thalassemia major and the molecular mechanism study.
    Fang S; Wu Z; Zhang X; Liu Y; Wang W; Chai L; Cai H; Yi J; Wang L; Chen Y; Lv X; Huang Y; Wang R; Chen P
    Biol Pharm Bull; 2007 Nov; 30(11):2084-7. PubMed ID: 17978480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of Novel Fetal Hemoglobin Inducers through Small Chemical Library Screening.
    Breveglieri G; Pacifico S; Zuccato C; Cosenza LC; Sultan S; D'Aversa E; Gambari R; Preti D; Trapella C; Guerrini R; Borgatti M
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33050052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.